TP53 and cancer: HBx-upregulated miR-29 family members could increase cell survival by targeting BCL-2 proteins (MCL-1) that retard apoptosis by contributing to the down regulation Caspase 9/3 driven apoptosis in the TP53 cancer pathway (105, 173, 174).